What is XCellR8?
Based in the United Kingdom, XCellR8 operates as a premier GLP-accredited laboratory dedicated to animal-free safety and efficacy testing. The company distinguishes itself by providing sophisticated, human-relevant data that satisfies stringent international regulatory requirements. Their service portfolio, which spans safety assessments, claims substantiation, and bespoke testing protocols, serves a broad spectrum of clients ranging from agile start-ups to multinational corporations such as Unilever. By eliminating the reliance on animal-derived components, XCellR8 addresses the critical market demand for ethical transparency and regulatory compliance in the cosmetics, personal care, and chemical industries.
How much funding has XCellR8 raised?
XCellR8 has raised a total of $140K across 1 funding round:
Unspecified
$140K
Unspecified (2021): $140K with participation from AstraZeneca and Unilever
Key Investors in XCellR8
AstraZeneca
A global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in oncology and biopharmaceuticals.
Unilever
A multinational consumer goods company that invests in sustainable innovation and ethical supply chain solutions to support its diverse portfolio of global brands.
What's next for XCellR8?
With this late-stage capital, XCellR8 is poised to accelerate its operational capacity and expand its reach within the global testing market. The strategic focus will likely involve enhancing its laboratory infrastructure to accommodate increased demand for vegan-certified and ethically sourced product validation. As regulatory bodies worldwide continue to tighten standards regarding animal testing, XCellR8 is strategically aligned to capture significant market share. The company's trajectory suggests a move toward broader international standardization, potentially influencing global safety protocols and reinforcing its commitment to a 100% animal-free future in scientific research.
See full XCellR8 company page
